The Great Ozempic Hustle. The GLP-1 saga epitomizes the unsustainable corruption within our medical system (condensed version of a previous article). By A Midwestern Doctor (09/19/24)
Story at a Glance
This article address the controversy around GLP-1 weight loss drugs such as Trulicity, Wegovy, Mounjaro, Byetta, and Ozempic (all these “semaglutide” drugs work similarly, with Ozempic being best known). The article also explores the common causes of obesity, including those rarely discussed.
In early 2023, JP Morgan’s private annual healthcare conference with pharmaceutical industry leaders and investors highlighted anti-obesity and Alzheimer’s drugs as the next big money-makers. FDA head Dr. Robert M. Califf was its keynote speaker. [ED NOTE: Can you say “conflict of interest?”]
Since then, the FDA has promoted these drugs, particularly the anti-obesity medication Ozempic.
A massive marketing push is ongoing to put everyone, including children, on Ozempic — eerily similar to what happened with Fen-Phen, a temporary weight loss drug later pulled for causing severe heart and lung issues.
Ozempic comes with many serious side effects, including paralyzing the digestive tract.
To illustrate just one example of FDA capture: Two unsafe and ineffective Alzheimer’s drugs were so bad that three regulators on the FDA advisory panel quit after the first drug was approved, and the second manufacturer discontinued its failed drug (which the FDA approved and glowingly touted without any advisory panel).Key Topics
Pharmaceutical Sales
The Rise of Ozempic (semaglutide)
The Rise and Fall of Fen-Phen
The Risks and Benefits of Ozempic
What Causes Obesity
Conclusion
The Ozempic story clearly illustrates that medical guidelines are largely driven by economic considerations rather than scientific evidence.
The corruption within our medical system finally has reached the point of absurdity, with many clearly dangerous drugs being pushed onto the public by government regulators. But FINALLY, the public is starting to see through [some of] their lies and becoming less likely to “trust the experts.”
Unlike with Fen-Phen (which regulators finally removed from the market), the resistance to Ozempic is coming from everyday Americans who do not want these unnecessary and damaging drugs pushed on themselves or their kids.
